Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Regular post-discharge follow-up with a nephrologist is recommended for post-AKI survivors; however, accessibility barriers, particularly among patients with multiple comorbidities or those living in remote areas, often limit continuity of care. Telemedicine offers a potential solution, but evidence in post-AKI populations remains limited.
This single-center, open-label, randomized controlled trial was conducted at Thammasat University Hospital, Thailand. Adults who survived hospitalization with stage 2–3 AKI and lived ≥15 km from the hospital were randomized to telemedicine follow-up using the secure “TUH Telemed” application or conventional face-to-face follow-up for six months. The primary outcome was feasibility, assessed using three process indicators: (i) follow-up adherence, (ii) serum creatinine measurement, and (iii) blood pressure (BP) measurement. Secondary outcomes included clinical (mortality, readmission, CKD progression, recurrent AKI, BP control) and patient-centered outcomes (satisfaction, waiting time, travel time, and travel cost).
A total of 58 post-AKI patients were enrolled, with 29 assigned to conventional face-to-face follow-up group and 29 to telemedicine follow-up group. The mean age was 63.9 ± 13.8 years, and 57% were male. Baseline characteristics were comparable between groups. At six months, follow-up adherence and blood pressure measurement rates were similar between the telemedicine and face-to-face groups (89.6% vs. 93.1%, p = 0.70, and 92.3% vs. 100%, p = 0.15, respectively). However, serum creatinine measurement was significantly lower in the telemedicine group (57.7% vs. 100%, p < 0.001). There were no significant differences in mortality, CKD progression, recurrent AKI or BP control between groups, whereas hospital readmission occurred more frequently in the face-to-face group (20.7% vs. 3.4%, p = 0.044). Patients in the telemedicine group had significantly lower travel costs, shorter travel time, and shorter waiting time. Patient satisfaction remained high in both groups (9.2 ± 0.8 vs. 9.1 ± 0.7, p = 0.46).
Telemedicine follow-up for post-AKI patients was feasible and yielded clinical outcomes comparable to traditional face-to-face follow-up. It also significantly reduced travel and waiting times while maintaining high patient satisfaction.
